Innovating Works

AIDViC

Financiado
Antibiotic intracellular delivery via virus like carriers
Taking inspiration from natural carriers, such as viruses, a new technology has been developed in our laboratories part of an ongoing ERC starting grant project, Molecular Engineering of Virus-like Carriers (MEViC). We created syn... Taking inspiration from natural carriers, such as viruses, a new technology has been developed in our laboratories part of an ongoing ERC starting grant project, Molecular Engineering of Virus-like Carriers (MEViC). We created synthetic viruses using polymers and thus safer materials. They are able of delivering high payload of specific drugs into cells with no detrimental effect. While testing for anticancer therapies, we identified a synthetic virus capable of targeting almost exclusively macrophages. We performed preliminary work showing that this can be successfully applied to deliver antibiotics to rid of intracellular pathogens. This has now open a completely new possibility whereas we can expand our technology for the treatment of several infections as well as to contribute to the ongoing efforts in tackling antibiotic resistance. ver más
31/12/2018
UNIVERSITY COLLEGE...
149K€
Perfil tecnológico estimado
Duración del proyecto: 18 meses Fecha Inicio: 2017-06-14
Fecha Fin: 2018-12-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2018-12-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
ERC-PoC-2016: ERC-Proof of Concept-2016
Cerrada hace 8 años
Presupuesto El presupuesto total del proyecto asciende a 149K€
Líder del proyecto
UNIVERSITY COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5